Interleukin-6 versus C-reactive Protein as Markers for Early Detection of Bacteremia in Febrile Neutropenia in Pediatric Population

Abstract

Introduction: Systemic infection leading to multiorgan failure during neutropenia is one of the leading causes of treatment-related mortality among children receiving chemotherapy. Reliable markers are needed to diagnose or rule out infection, to reduce the empirical use of broad-spectrum antibiotic therapy. Aims and Objectives: The aim is to compare the role of interleukin-6 versus C-reactive protein (CRP) as markers of sepsis in febrile neutropenia in pediatric patients while on chemotherapy for malignancy. Materials and Methods: This was a prospective observational study carried out in the Department of Paediatrics of a tertiary care Hospital in South India. All children with malignancy in the age group from 1 month to 18 years diagnosed to have febrile neutropenia during any phase of chemotherapy were included in the study. Multiple episodes of febrile neutropenia in the same child were analyzed as separate episodes. Results: Thirty-two episodes of febrile neutropenia were analyzed. There were 7 microbiologically documented infections (MDI), 19 clinically documented infections and 6 episodes of fever of unknown origin. Out of the 7 MDI, 5 were Gram-negative sepsis and 2 were Gram-positive sepsis. Gram-negative sepsis had a much higher median IL-6 value (169) than Gram-positive sepsis (17.5) and sterile blood cultures (52). However, median value of CRP was only slightly higher in Gram-positive sepsis (85.5) than in Gram-negative sepsis (60.7) and sterile blood cultures (44.2). Conclusion: In this study, higher IL-6 values predicted Gram-negative sepsis better than CRP.

Keywords

C-reactive protein - febrile neutropenia - interleukin-6

Publication History

Received: 18 December 2019

Accepted: 03 May 2020

Article published online:
17 May 2021

• References

• 1 von Lilienfeld-Toal M, Dietrich MP, Glasmacher A, Lehmann L, Breig P, Hahn C. et al. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: Procalcitonin and IL-6 are more reliable than C-reactive protein. Eur J Clin Microbiol Infect Dis 2004; 23: 539-44
• 2 Holub M, Lawrence DA, Andersen N, Davidová A, Beran O, Marešová V. et al. Cytokines and chemokines as biomarkers of community-acquired bacterial infection. Mediators Inflamm 2013; 2013: 190145
• 3 Hou T, Huang D, Zeng R, Ye Z, Zhang Y. Accuracy of serum interleukin (IL)-6 in sepsis diagnosis: A systematic review and meta-analysis. Int J Clin Exp Med 2015; 8: 15238-45
• 4 Engel A, Mack E, Kern P, Kern WV. An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, Gram-negative bacteremia and complicated infection in neutropenic cancer patients. Infection 1998; 26: 213-21
• 5 Oda S, Hirasawa H, Shiga H, Nakanishi K, Matsuda K, Nakamua M. Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis. Cytokine 2005; 29: 169-75
• 6 de Naurois J, Novitzky-Basso I, Gill MJ, Marti FM, Cullen MH, Roila F. et al. Management of febrile neutropenia: ESMO Clinical Practice Guidelines. Ann Oncol 2010; 21 Suppl 5: v252-6
• 7 Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA. et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases Society of America. Clin Infect Dis 2011; 52: 56-93
• 8 Buchheidt D, Böhme A, Cornely OA, Fätkenheuer G, Fuhr HG, Heussel G. et al. Infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Diagnosis and treatment of documented infections in neutropenic patients – Recommendations of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2003; 82 Suppl 2: S127-32
• 9 Stiller C. editor Childhood Cancer in Britain: Incidence Survival, Mortality. Oxford: Oxford University Press; 2007
• 10 Gurney JG, Bondy ML. Epidemiology of childhood cancer. In: Pizzo PA, Poplack DG. editors Principles and Practice of Pediatric Oncology. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2006: 2-14
• 11 Arora RS, Eden TO, Kapoor G. Epidemiology of childhood cancer in India. Indian J Cancer 2009; 46: 264-73
• 12 Escande MC, Herbrecht R. Prospective study of bacteraemia in cancer patients. Results of a French multicentre study. Support Care Cancer 1998; 6: 273-80
• 13 Mandal PK, Maji SK, Dolai TK, De R, Dutta S, Saha S. et al. Micro-organisms Associated with febrile neutropenia in patients with Haematological Malignancies in a Tertiary Care Hospital in Eastern India. Indian J Hematol Blood Transfus 2015; 31: 46-50
• 14 Taj M, Farzana T, Shah T, Maqsood S, Ahmed SS, Shamsi TS. Clinical and microbiological profile of pathogens in febrile neutropenia in hematological malignancies: A single center prospective analysis. J Oncol 2015; 2015: 596504
• 15 Patel RT, Deen KI, Youngs D, Warwick J, Keighley MR. Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsis. Br J Surg 1994; 81: 1306-8
• 16 Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993; 103: 565-75